Skip to main content
Equibles
AEMD logo

AEMD · Aethlon Medical Inc · Webcasts, Transcripts & Audio

Track AEMD — free

Use AEMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AEMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.45 -0.18 (-2.71%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — cleared Aug 13, 2026

The latest filing no longer states the doubt (first flagged Jun 10, 2026).

View the 10-Q filed Aug 13, 2026
Market Cap
$4.54M
Shares
711,136
Volume · Oct 2 40.93K Avg daily vol (43 sessions) 3.79M

Aethlon Medical Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Aethlon Medical Inc (AEMD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼100% $ −$3.81M '23 Q2 22-11-14 ▼100% $ −$2.85M '23 Q3 23-02-13 LATEST ▲4278.2% $574,245 −$2.47M '23 Q4 23-06-28
Earnings call
FY27 · Q1
2026-08-13
Aethlon Medical Inc (AEMD) Q1 2027 Earnings Call
Diluted EPS
$-4.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-07-16
Aethlon Medical Inc (AEMD) July 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q4
2026-06-10
Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-02-12
Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call
Diluted EPS
$-12.25
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-12
Aethlon Medical Inc (AEMD) Q2 2026 Earnings Call Transcript
Balanced tone Australian oncology trial progress Extracellular vesicle (EV) and biomarker data Long COVID and preclinical R&D
Diluted EPS
$-18.70
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-08-13
Aethlon Medical Inc (AEMD) Q1 2026 Earnings Call Transcript
Positive tone Australian oncology trial progress Long COVID and preclinical R&D Australian R&D tax rebate advantage
Diluted EPS
$-42.42
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-06-27
Aethlon Medical Inc (AEMD) Q4 2025 Earnings Call Transcript
Positive tone Hemopurifier oncology trial in Australia Long COVID / UCSF collaboration India oncology study approval
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-02-12
Aethlon Medical Inc (AEMD) Q3 2025 Earnings Call Transcript
Positive tone Oncology clinical trial progress Infectious disease / pandemic preparedness Operating expense reduction and runway
Diluted EPS
$-50.25
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-13
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Transcript
Positive tone Oncology clinical trial in Australia Australian R&D tax credit Indian clinical trial expansion
Diluted EPS
$-80.55
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-08-14
Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Transcript
Positive tone Oncology clinical trial progress Near-term clinical milestones Personnel changes and restructuring
Diluted EPS
$-138.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-06-27
Aethlon Medical Inc (AEMD) Q4 2024 Earnings Call Transcript
Positive tone Oncology clinical trial progress H5N1 Avian Influenza opportunity Cash position and finances
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-02-14
Aethlon Medical Inc (AEMD) Q3 2024 Earnings Call Transcript
Cautious tone Oncology trial in India/Australia COVID-19 trial in India Inconclusive preclinical data
Diluted EPS
$-548.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2023-11-14
Aethlon Medical Inc (AEMD) Q2 2024 Earnings Call Transcript
Diluted EPS
$-488.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-08-10
Aethlon Medical Inc (AEMD) Q1 2024 Earnings Call Transcript
Diluted EPS
$-540.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-06-28
Aethlon Medical Inc (AEMD) Q4 2023 Earnings Call Transcript
Revenue
$574,245*
▲ 4278.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-02-13
Aethlon Medical Inc (AEMD) Q3 2023 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Diluted EPS
$-496.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-14
Aethlon Medical Inc (AEMD) Q2 2023 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Diluted EPS
$-736.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-09
Aethlon Medical Inc (AEMD) Q1 2023 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Diluted EPS
$-760.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-06-28
Aethlon Medical Inc (AEMD) Q4 2022 Earnings Call Transcript
Revenue
$13,116*
▼ 61.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-14
Aethlon Medical Inc (AEMD) Q3 2022 Earnings Call Transcript
Revenue
$17,117
▼ 97.3% YoY
Diluted EPS
$-640.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-11-09
Aethlon Medical Inc (AEMD) Q2 2022 Earnings Call Transcript
Revenue
$131,966
Diluted EPS
$-520.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-09
Aethlon Medical Inc (AEMD) Q1 2022 Earnings Call Transcript
Revenue
$131,966
Diluted EPS
$-640.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-06-24
Aethlon Medical Inc (AEMD) Q4 2021 Earnings Call Transcript
Revenue
$34,233*
▼ 83.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-10
Aethlon Medical Inc (AEMD) Q3 2021 Earnings Call Transcript
Revenue
$624,871
▲ 51.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-10-28
Aethlon Medical Inc (AEMD) Q2 2021 Earnings Call Transcript
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-08-11
Aethlon Medical Inc (AEMD) Q1 2021 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-06-25
Aethlon Medical Inc (AEMD) Q4 2020 Earnings Call Transcript
Revenue
$206,729*
▲ 158.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-02-10
Aethlon Medical Inc (AEMD) Q3 2020 Earnings Call Transcript
Revenue
$413,458
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2019-09-30
Aethlon Medical Inc (AEMD) Q2 2020 Earnings Call Transcript
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2019-06-30
Aethlon Medical Inc (AEMD) Q1 2020 Earnings Call Transcript
Revenue
$30,000
▼ 79.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–30 of 30 webcasts
Key facts CIK 882291 CUSIP 00808Y703 Visit website Investor relations